References
- Lee C, Agrawal R, Pavesio C. Ocular tuberculosis – A clinical conundrum. Ocul Immunol Inflamm. 2016;24(2):237–242. doi:10.3109/09273948.2014.985387.
- Ang M, Chee SP. Controversies in ocular tuberculosis. Br J Ophthalmol. 2017;101(1):6–9. doi:10.1136/bjophthalmol-2016-309531.
- Gupta V, Gupta A, Rao NA. Intraocular tuberculosis – an update. Surv Ophthalmol. 2007;52(6):561–587. doi:10.1016/j.survophthal.2007.08.015.
- Abu El-Asrar AM, Abouammoh M, Al-Mezaine HS. Tuberculous uveitis. Int Ophthalmol Clin. 2010;50:19–39. doi:10.1097/IIO.0b013e3181d2ccb9.
- BenEzra D, Cohen E, Maftzir G. Uveitis in children and adolescents. Br J Ophthalmol. 2005;89:444–448. doi:10.1136/bjo.2004.050609.
- Smith JA, Mackensen F, Sen HN, et al. Epidemiology and course of disease in childhood uveitis. Ophthalmology. 2009;116:1544–1551. doi:10.1016/j.ophtha.2009.05.002.
- Rathinam SR, Namperumalsamy P. Global variation and pattern changes in epidemiology of uveitis. Indian J Ophthalmol. 2007;55:173–183. doi:10.4103/0301-4738.31936.
- Edelsten C, Reddy MA, Stanford MR, Graham EM. Visual loss associated with pediatric uveitis in English primary and referral centers. Am J Ophthalmol. 2003;135:676–680. doi:10.1016/S0002-9394(02)02148-7.
- Wakabayashi T, Morimura Y, Miyamoto YOA. Changing pattern of intraocular inflammatory disease in Japan. Ocul Immunol Inflamm. 2003;11:277–286. doi:10.1076/ocii.11.4.277.18260.
- Gupta A, Sharma A, Bansal R, Sharma K. Classification of intraocular tuberculosis. Ocul Immunol Inflamm. 2015;23(1):7–13. doi:10.3109/09273948.2014.967358.
- Rosenbaum JT. To be or not TB? Br J Ophthalmol. 2014;98(8):999–1000. doi:10.1136/bjophthalmol-2014-304883.
- Kee AR, Gonzalez-Lopez JJ, Al-Hity A, et al. Anti tubercular therapy for intraocular tuberculosis: a systematic review and meta-analysis. Surv Ophthalmol. 2016;61(5):628–653. doi:10.1016/j.survophthal.2016.03.001.
- Agrawal R, Gunasekeran DV, Raje D, et al. Global variations and challenges with tubercular uveitis in the Collaborative Ocular Tuberculosis Study. Invest Ophthalmol Vis Sci. 2018;59(10):4162–4171. doi:10.1167/iovs.18-24102.
- Agrawal R, Gunasekeran DV, Grant R, et al. Clinical features and outcomes of patients with tubercular uveitis treated with antitubercular therapy in the Collaborative Ocular Tuberculosis Study (COTS)-1. JAMA Ophthalmol. 2017;135(12):1318–1327. doi:10.1001/jamaophthalmol.2017.4485.
- Agarwal A, Agrawal R, Gunasekaran DV, et al. The Collaborative Ocular Tuberculosis Study (COTS)-1 report 3: polymerase chain reaction in the diagnosis and manage- ment of tubercular uveitis: global trends. Ocul Immunol Inflamm. 2019;27(3):465–473. doi:10.1080/09273948.2017.1406529.
- Agarwal R, Gunasekaran DV, Agrawal A, et al. The Collaborative Ocular Tuberculosis Study (COTS)-1: a multinational description of the spectrum of choroidal involvement in 245 patients with tubercular uveitis. Ocul Immunol Inflamm. 2018;29:1–11. doi:10.1080/09273948.2018.1489061.
- Gunasekeran DV, Agrawal R, Agarwal A, et al. The Collaborative Ocular Tuberculosis Study (COTS)-1: a multinational review of 251 patients with tubercular retinal vasculitis. Retina. 2019;39(8):1623–1630. doi:10.1097/IAE.0000000000002194.
- Testi I, Agrawal R, Mahajan S, et al. Tubercular Uveitis: nuggets from Collaborative Ocular Tuberculosis Study (COTS)-1. Ocul Immunol Inflamm. 2019;25:1–9.
- World Health Organization (WHO). Global tuberculosis report. 2018. www.who.int/tb/publications/global_ report/en/.
- Gupta A, Bansal R, Gupta V, et al. Ocular signs predictive of tubercular uveitis. Am J Ophthalmol. 2010;149(4):562–570. doi:10.1016/j.ajo.2009.11.020.
- Kaur S, Aggarwal K, Agarwal A, et al. Clinical course and outcomes of pediatric tubercular Uveitis in North India. Ocul Immunol Inflamm. 2018;26(6):859–864. doi:10.1080/09273948.2017.1296579.
- Tugal-Tutkun I. Pediatric uveitis. J Ophthalmic Vis Res. 2011;6:259–269.